Nobel Prize Honors Scientists Behind mRNA Vaccines Against Covid-19
Portfolio Pulse from Piero Cingari
The Nobel Assembly has awarded the Nobel Prize in medicine to Katalin Kariko and Drew Weissman for their work in the development of mRNA vaccines against Covid-19. Their research paved the way for companies like Moderna Inc. and the Pfizer Inc. – BioNTech SE partnership to rapidly develop mRNA-based vaccines. Despite this, shares of Moderna and Pfizer have experienced a 43% and 35% decline year-to-date respectively.
October 02, 2023 | 12:55 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Moderna's stock has declined 43% year-to-date despite the company's pivotal role in mRNA vaccine development.
The decline in Moderna's stock price despite its role in mRNA vaccine development suggests that the market has already priced in the benefits of the vaccine and is now focusing on other factors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Pfizer's stock has declined 35% year-to-date despite the company's role in mRNA vaccine development.
The decline in Pfizer's stock price despite its role in mRNA vaccine development suggests that the market has already priced in the benefits of the vaccine and is now focusing on other factors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEUTRAL IMPACT
BioNTech SE, in partnership with Pfizer, played a key role in the development of mRNA vaccines, but the impact on its stock price is not mentioned in the article.
While BioNTech's role in mRNA vaccine development is significant, the article does not provide information on how this has impacted the company's stock price.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80